{
  "claim_id": "claim_006",
  "claim": "Flublok is produced using a novel production platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS).",
  "document": {
    "pdf_name": "Liu_et_al.__2024_",
    "source_pdf": "data/clinical_files/Liu et al. (2024).pdf",
    "total_pages": 13,
    "total_blocks": 124,
    "total_characters": 39807
  },
  "extraction_result": {
    "success": true,
    "total_snippets_found": 2,
    "error": null
  },
  "extracted_evidence": [
    {
      "id": 1,
      "quote": "The purified and trimeric recombinant HA proteins were expressed from the baculovirus system using the established procedures 45.",
      "relevance_explanation": "This quote directly states that recombinant HA proteins (the antigen in Flublok) are produced using a baculovirus system, which is the core of the BEVS platform."
    },
    {
      "id": 2,
      "quote": "a recombinant influenza vaccine (Flublok Quadrivalent by SanofiPasteur, RIV4).",
      "relevance_explanation": "This quote identifies Flublok as a recombinant influenza vaccine, which is necessary context for understanding that the recombinant HA described above is the antigen in Flublok."
    }
  ],
  "model_used": "gpt-4.1"
}